Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes.

Suzuki HI, Matsuyama H, Noguchi M, Yao T, Komatsu N, Mano H, Sugimoto K, Miyazono K.

Leukemia. 2013 Oct;27(10):2107-11. doi: 10.1038/leu.2013.121. Epub 2013 Apr 18. No abstract available.

PMID:
23594704
2.

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.

Peveling-Oberhag J, Crisman G, Schmidt A, Döring C, Lucioni M, Arcaini L, Rattotti S, Hartmann S, Piiper A, Hofmann WP, Paulli M, Küppers R, Zeuzem S, Hansmann ML.

Leukemia. 2012 Jul;26(7):1654-62. doi: 10.1038/leu.2012.29. Epub 2012 Feb 6.

PMID:
22307176
3.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Foà R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605
4.

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.

Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, Tosi I, Vermeer MH, Tramonti D, Saunders NJ, Boultwood J, Wainscoat JS, Pezzella F, Whittaker SJ, Tensen CP, Hatton CS, Lawrie CH.

Blood. 2010 Aug 19;116(7):1105-13. doi: 10.1182/blood-2009-12-256719. Epub 2010 May 6.

5.

Development of a metastatic fluorescent Lewis Lung carcinoma mouse model: identification of mRNAs and microRNAs involved in tumor invasion.

Rask L, Fregil M, Høgdall E, Mitchelmore C, Eriksen J.

Gene. 2013 Mar 15;517(1):72-81. doi: 10.1016/j.gene.2012.12.083. Epub 2013 Jan 4.

PMID:
23296057
6.

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.

Solomides CC, Evans BJ, Navenot JM, Vadigepalli R, Peiper SC, Wang ZX.

Acta Cytol. 2012;56(6):645-54. doi: 10.1159/000343473. Epub 2012 Nov 24.

PMID:
23207443
7.

Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.

Rücker FG, Russ AC, Cocciardi S, Kett H, Schlenk RF, Botzenhardt U, Langer C, Krauter J, Fröhling S, Schlegelberger B, Ganser A, Lichter P, Zenz T, Döhner H, Döhner K, Bullinger L.

Leukemia. 2013 Feb;27(2):353-61. doi: 10.1038/leu.2012.208. Epub 2012 Jul 19.

PMID:
22810507
8.

MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.

Hou Z, Xie L, Yu L, Qian X, Liu B.

Med Oncol. 2012 Jun;29(2):886-92. doi: 10.1007/s12032-011-9862-7. Epub 2011 Feb 24.

PMID:
21347720
9.

miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.

Endo Y, Toyama T, Takahashi S, Yoshimoto N, Iwasa M, Asano T, Fujii Y, Yamashita H.

Endocr Relat Cancer. 2013 Feb 18;20(1):91-102. doi: 10.1530/ERC-12-0207. Print 2013 Feb.

10.

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.

Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK.

Med Oncol. 2012 Jun;29(2):618-26. doi: 10.1007/s12032-011-9923-y. Epub 2011 Apr 24.

PMID:
21516486
11.

Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.

Bae J, Won M, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH, Suh DS.

Int J Gynecol Cancer. 2012 May;22(4):561-5. doi: 10.1097/IGC.0b013e31824927db.

PMID:
22543862
12.

miRNA expression profiles of oral squamous cell carcinomas.

Gombos K, Horváth R, Szele E, Juhász K, Gocze K, Somlai K, Pajkos G, Ember I, Olasz L.

Anticancer Res. 2013 Apr;33(4):1511-7.

PMID:
23564792
13.

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.

Mahadevan D, Spier C, Della Croce K, Miller S, George B, Riley C, Warner S, Grogan TM, Miller TP.

Mol Cancer Ther. 2005 Dec;4(12):1867-79.

14.

Mantle cell lymphoma: transcriptional regulation by microRNAs.

Di Lisio L, Gómez-López G, Sánchez-Beato M, Gómez-Abad C, Rodríguez ME, Villuendas R, Ferreira BI, Carro A, Rico D, Mollejo M, Martínez MA, Menárguez J, Díaz-Alderete A, Gil J, Cigudosa JC, Pisano DG, Piris MA, Martínez N.

Leukemia. 2010 Jul;24(7):1335-42. doi: 10.1038/leu.2010.91. Epub 2010 May 20.

PMID:
20485376
15.

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

Arribas AJ, Campos-Martín Y, Gómez-Abad C, Algara P, Sánchez-Beato M, Rodriguez-Pinilla MS, Montes-Moreno S, Martinez N, Alves-Ferreira J, Piris MA, Mollejo M.

Blood. 2012 Jan 19;119(3):e9-e21. doi: 10.1182/blood-2011-02-339556. Epub 2011 Nov 22.

16.

Analysis of microRNA expression profiles during the cell cycle in synchronized HeLa cells.

Zhou JY, Ma WL, Liang S, Zeng Y, Shi R, Yu HL, Xiao WW, Zheng WL.

BMB Rep. 2009 Sep 30;42(9):593-8.

17.

MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.

Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W.

Med Oncol. 2012 Jun;29(2):1037-43. doi: 10.1007/s12032-011-9975-z. Epub 2011 May 12.

PMID:
21562850
18.

The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.

Bomben R, Gobessi S, Dal Bo M, Volinia S, Marconi D, Tissino E, Benedetti D, Zucchetto A, Rossi D, Gaidano G, Del Poeta G, Laurenti L, Efremov DG, Gattei V.

Leukemia. 2012 Jul;26(7):1584-93. doi: 10.1038/leu.2012.44. Epub 2012 Feb 20.

PMID:
22343732
19.

Impact of microRNA in normal and pathological respiratory epithelia.

Giovannini-Chami L, Grandvaux N, Zaragosi LE, Robbe-Sermesant K, Marcet B, Cardinaud B, Coraux C, Berthiaume Y, Waldmann R, Mari B, Barbry P.

Methods Mol Biol. 2011;741:171-91. doi: 10.1007/978-1-61779-117-8_12.

PMID:
21594785
20.

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status.

Faraoni I, Laterza S, Ardiri D, Ciardi C, Fazi F, Lo-Coco F.

J Hematol Oncol. 2012 Jun 8;5:26. doi: 10.1186/1756-8722-5-26.

Supplemental Content

Support Center